PLUS1
15.35
-1.62 (-9.55%)
-1.62 (-9.55%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,994,289 |
|
|||||
| News | - | ||||||
| Day High | 17.61 | Low High |
|||||
| Day Low | 14.22 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| -1.62 | -9.55% | 15.35 | 11:51:17 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 17.03 | 14.22 | 17.61 | 14.33 | 16.97 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,225 | 1,994,289 | US$ 16.42 | US$ 32,749,709 | - | 9.84 - 18.9583 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:58:29 | 10 | US$ 15.20 | USD |
Period:
Draw Mode:
Aclaris Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 1.02B | 66.68M | 64.28M | US$ 6.76M | US$ - | -1.63 | -13.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | -210.00k | 3.90% |
Aclaris Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 09/1/2023 | 23:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 07/1/2023 | 08:32 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 07/1/2023 | 08:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 06/1/2023 | 23:01 | GlobeNewswire Inc. | Aclaris Therapeutics Provides 2023 Outlook |
| 05/1/2023 | 10:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 17/12/2022 | 08:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 02/12/2022 | 14:06 | TipRanks | SVB Securities Keeps Their Buy Rating on Aclaris.. |
| 29/11/2022 | 23:00 | GlobeNewswire Inc. | Aclaris Therapeutics and Pediatrix Therapeutics Announce.. |
| 23/11/2022 | 08:14 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 23/11/2022 | 08:01 | GlobeNewswire Inc. | Aclaris Therapeutics Announces Key Leadership Transitions |
| 15/11/2022 | 09:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/11/2022 | 08:01 | GlobeNewswire Inc. | Aclaris Therapeutics to Participate in Two November.. |
Historical ACRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.95 | 18.54 | 14.22 | 17.10 | 578,424 | -1.60 | -9.44% |
| 1 Month | 14.77 | 18.54 | 14.22 | 17.01 | 410,830 | 0.58 | 3.93% |
| 3 Months | 16.95 | 18.9583 | 14.02 | 16.54 | 372,479 | -1.60 | -9.44% |
| 6 Months | 13.54 | 18.9583 | 12.825 | 16.16 | 354,847 | 1.81 | 13.37% |
| 1 Year | 11.61 | 18.9583 | 9.84 | 15.22 | 397,158 | 3.74 | 32.21% |
| 3 Years | 1.25 | 30.375 | 0.70 | 14.01 | 696,048 | 14.10 | 1,128.0% |
| 5 Years | 22.26 | 30.375 | 0.70 | 10.68 | 683,828 | -6.91 | -31.04% |